美女高潮喷水白浆后入在线观看_出a级黑粗大硬长爽猛视频_qvod日韩伦理电影_亚洲自偷自拍三级_成人黄片视频_精品综合无码在线观看_亚洲综合无码中文字幕伊人_亚洲男人天堂最新版_夫洗澡公强我了60分钟_免费看又爽又黄又猛的视频

過氧化還原酶3(PRDX3)多克隆抗體

Polyclonal Antibody to Peroxiredoxin 3 (PRDX3)

MER5; AOP-1; AOP1; SP-22; Antioxidant Protein 1; Thioredoxin-dependent peroxide reductase, mitochondrial

  • 過氧化還原酶3(PRDX3)多克隆抗體 產(chǎn)品包裝(模擬)
  • 過氧化還原酶3(PRDX3)多克隆抗體 產(chǎn)品包裝(模擬)
  • 過氧化還原酶3(PRDX3)多克隆抗體 DAB staining on IHC-P; Sample: Rat Cerebrum Tissue Primary Ab: 10μg/ml Rabbit Anti-Rat PRDX3 Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • PAF753Ra01.jpg Western Blot; Sample: Rat Cerebrum lysate Primary Ab: 0.1μg/ml Rabbit Anti-Rat PRDX3 Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • 過氧化還原酶3(PRDX3)多克隆抗體 Western Blot; Sample: Lane1: Rat Kidney lysate; Lane2: Rat Spinal cord lysate; Lane3: Rat Serum
    Primary Ab: 1μg/mL Rabbit Anti-Rat PRDX3 Antibody
    Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對PRDX3的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別PRDX3。

用法

免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學:5-20μg/mL;1:25-100
免疫細胞化學:5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種:Rattus norvegicus (Rat,大鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
URPF753Ra01 過氧化還原酶3(PRDX3)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAF753Ra01 過氧化還原酶3(PRDX3)多克隆抗體 WB; IHC
ULAF753Ra81 過氧化還原酶3(PRDX3)多克隆抗體(異硫氰酸熒光素標記) WB; IHC; ICC; IF.
ULAF753Ra71 過氧化還原酶3(PRDX3)多克隆抗體(生物素標記) WB; IHC; ICC.

參考文獻

雜志 參考文獻
PLoS One Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages [pubmed:27716839]
Journal?of?Experimental?&?Clinical?Cancer?Research Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway [Pubmed: 30454068]
留言咨詢